• Founded in 1999
  • Employees: 90

Description :

Cellectis develops innovative cancer products based on engineered T cells armed with a Chimeric Antigen Receptor (CAR) to target liquid and solid tumor

Headquarters :

8 rue de la Croix Jarry, paris

Related Posts

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.